Skip to content
Home / Companies / ABBV ABB
AbbVie Inc. (ABBV) S&P 500 XNYS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest ABBV Insider Trades AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Headquarters NORTH CHICAGO, IL
Employees 57,000
Listed 2012
Exchange XNYS https://www.abbvie.com SEC filings for ABBV on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 1 32,710 $8.18M Grant or award 2 196 Option exercise 2 65,420
ABBV Insider Transactions (Form 4) 45 59 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 14, 2026 ND Nicholas Donoghoe - Officer Option exercise Common Stock, $0.01 par value 32,710
Recent ABBV Form 8-K Filings 5
Recent ABBV Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 14, 2026 NICHOLAS DONOGHOE Officer 32,710 $8.18M View on EDGAR May 26, 2026 - -
ABBV Insider Trading - FAQ
What is the latest insider trade for ABBV? AbbVie Inc. (ABBV) had 3 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for ABBV runs to 59 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ABBV stock? No insider purchases of ABBV were filed in the last 90 days.
How many insiders are selling ABBV stock? 1 insider sale of ABBV was filed in the last 90 days, totaling $8.18M.
Where can I see ABBV SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks ABBV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ABBV insider buys? Create a free InsiderAlpha account and press Watch on this page to add ABBV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track ABBV insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $451.46B
P/E ratio 72.30
Dividend yield -
Average volume 6.53M
52 week high $267.47
52 week low $190.75
Today's high $259.00
Today's low $255.08
Open $258.67
Volume 3.22M
Previous close $258.15
Shares outstanding 1.77B Market cap
$451.46B
57,000 employees
ABBV Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 1 sale totaling $8.18M.
Most-Active ABBV Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 14, 2026 ND Nicholas Donoghoe - Officer Open-market sale Common Stock, $0.01 par value 32,710 $250.00 $8.18M
Aug 14, 2026 ND Nicholas Donoghoe - Officer Option exercise Option (Right to buy) 32,710 $0.00 -
Jun 30, 2026 ER Edward J. Rapp Grant or award Stock Equivalent Units 134 $251.64 $34K
May 8, 2026 TF Thomas J. Falk Grant or award Common Stock, $0.01 par value 1,118 $0.00 -
May 8, 2026 ER Edward J. Rapp Grant or award Common Stock, $0.01 par value 1,118 $0.00 -
May 8, 2026 SQ Susan E. Quaggin Grant or award Common Stock, $0.01 par value 1,118 $0.00 -
May 8, 2026 MM Melody B. Meyer Grant or award Common Stock, $0.01 par value 1,118 $0.00 -
May 8, 2026 BH Brett J. Hart Grant or award Common Stock, $0.01 par value 1,118 $0.00 -
Mar 31, 2026 ER Edward J. Rapp Grant or award Stock Equivalent Units 155 $217.49 $34K
Feb 27, 2026 DP David Ryan Purdue - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 2,108 $232.08 $489K
Mar 4, 2026 DP David Ryan Purdue - Officer Open-market sale Common Stock, $0.01 par value 5,230 $233.56 $1.22M
Feb 27, 2026 DC Demetris D. Crum - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 1,594 $232.08 $370K
Feb 27, 2026 RT Roopal Thakkar - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 8,037 $232.08 $1.87M
Feb 27, 2026 RM Robert A. Michael - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 36,523 $232.08 $8.48M
Feb 27, 2026 JS Jeffrey Ryan Stewart - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 23,812 $232.08 $5.53M
Feb 27, 2026 PS Perry C. Siatis - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 14,850 $232.08 $3.45M
Mar 2, 2026 PS Perry C. Siatis - Officer Open-market sale Common Stock, $0.01 par value 5,777 $233.51 $1.35M
Mar 2, 2026 PS Perry C. Siatis - Officer Open-market sale Common Stock, $0.01 par value 10,291 $234.66 $2.41M
Mar 2, 2026 PS Perry C. Siatis - Officer Open-market sale Common Stock, $0.01 par value 2,600 $235.26 $612K
Feb 27, 2026 SR Scott T. Reents - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 21,638 $232.08 $5.02M
Feb 27, 2026 AS Azita Saleki-Gerhardt - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 16,309 $232.08 $3.78M
Feb 27, 2026 DP David Ryan Purdue - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 2,692 $232.08 $625K
Feb 27, 2026 ND Nicholas Donoghoe - Officer Tax withholding / forfeiture Common Stock, $0.01 par value 12,874 $232.08 $2.99M
Feb 25, 2026 PS Perry C. Siatis - Officer Option exercise Common Stock, $0.01 par value 7,314 $149.62 $1.09M
Feb 25, 2026 PS Perry C. Siatis - Officer Option exercise Common Stock, $0.01 par value 7,775 $175.28 $1.36M
Feb 25, 2026 PS Perry C. Siatis - Officer Option exercise Common Stock, $0.01 par value 7,292 $192.86 $1.41M
Feb 25, 2026 PS Perry C. Siatis - Officer Open-market sale Common Stock, $0.01 par value 22,381 $230.00 $5.15M
Feb 25, 2026 PS Perry C. Siatis - Officer Option exercise Option (Right to buy) 7,314 $149.62 $1.09M
Feb 25, 2026 PS Perry C. Siatis - Officer Option exercise Option (Right to buy) 7,775 $175.28 $1.36M
Feb 25, 2026 PS Perry C. Siatis - Officer Option exercise Option (Right to buy) 7,292 $192.86 $1.41M
Feb 18, 2026 RT Roopal Thakkar - Officer Grant or award Common Stock, $0.01 par value 6,015 $0.00 -
Feb 18, 2026 RT Roopal Thakkar - Officer Grant or award Common Stock, $0.01 par value 2,138 $0.00 -
Feb 18, 2026 RT Roopal Thakkar - Officer Grant or award Common Stock, $0.01 par value 3,346 $0.00 -
Feb 18, 2026 RT Roopal Thakkar - Officer Grant or award Common Stock, $0.01 par value 6,638 $0.00 -
Feb 18, 2026 RT Roopal Thakkar - Officer Grant or award Option (Right to buy) 21,937 $0.00 -
$ACET
Adicet Bio, Inc.
$IONS
IONIS PHARMACEUTICALS INC
David Ryan Purdue - OfficerOpen-market sale$1.22M
